"The reason that we need a big pharma partner along us at one point is to secure global reach but it's also because of investments into manufacturing," CEO Adam Steensberg told Reuters after the company reported second-quarter earnings.
from Health News | Latest Healthcare Sector & Healthcare Industry news, Information and Updates: ET HealthWorld : ETHealthworld.com https://ift.tt/CTyerFM
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment